Broadleaf Partners’s Cintas CTAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Sell
1,409
-42,697
-97% -$7.38M 0.05% 77
2026
Q1
$7.46M Sell
44,106
-1,757
-4% -$337K 1.74% 22
2025
Q4
$8.63M Sell
45,863
-106
-0.2% -$20K 1.82% 22
2025
Q3
$9.44M Sell
45,969
-742
-2% -$158K 1.97% 24
2025
Q2
$10.4M Sell
46,711
-37
-0.1% -$7.96K 2.29% 16
2025
Q1
$9.61M Buy
46,748
+16,428
+54% +$3.27M 2.52% 14
2024
Q4
$5.54M Buy
30,320
+13,222
+77% +$2.78M 1.29% 30
2024
Q3
$3.52M Buy
17,098
+15,698
+1,121% +$3.03M 0.83% 35
2024
Q2
$245K Hold
1,400
0.06% 74
2024
Q1
$240K Hold
1,400
0.06% 77
2023
Q4
$211K Buy
+1,400
New +$188K 0.06% 81

Other funds holding CTAS

Broadleaf Partners's CTAS Position: Q2 2026 in Review

Broadleaf Partners reduced its Cintas (CTAS) stake by 97% in Q2 2026, selling an estimated $7.38M and leaving 1,409 shares worth $240K. The position accounts for 0.05% of the portfolio, ranked #77.

Broadleaf Partners first reported a position in CTAS in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.4M in Q2 2025. 1,430 funds tracked by Wall St. Rank hold CTAS as of Q2 2026.

  • Broadleaf Partners held 1,409 shares of Cintas worth $240K as of Q2 2026.
  • Broadleaf Partners sold 42,697 Cintas shares in Q2 2026, an estimated $7.38M.
  • Cintas made up 0.05% of Broadleaf Partners's portfolio in Q2 2026, its #77 holding.
  • Broadleaf Partners first reported a position in Cintas in Q4 2023 and has held it in 11 quarters since.
  • Broadleaf Partners's Cintas position peaked at $10.4M in Q2 2025.
  • 1,430 funds tracked by Wall St. Rank held Cintas as of Q2 2026.

Based on Broadleaf Partners's 13F filing for Q2 2026, filed 13 Aug 2026.